[go: up one dir, main page]

FI20011703L - Jodidia ja jodaattia sisältävä stabiloitu oraalinen farmaseuttinen koostumus sekä menetelmä - Google Patents

Jodidia ja jodaattia sisältävä stabiloitu oraalinen farmaseuttinen koostumus sekä menetelmä Download PDF

Info

Publication number
FI20011703L
FI20011703L FI20011703A FI20011703A FI20011703L FI 20011703 L FI20011703 L FI 20011703L FI 20011703 A FI20011703 A FI 20011703A FI 20011703 A FI20011703 A FI 20011703A FI 20011703 L FI20011703 L FI 20011703L
Authority
FI
Finland
Prior art keywords
iodate
pharmaceutical composition
composition containing
oral pharmaceutical
containing iodide
Prior art date
Application number
FI20011703A
Other languages
English (en)
Swedish (sv)
Other versions
FI20011703A0 (fi
FI20011703A7 (fi
Inventor
Yongjun Duan
Kirk Dinehart
John Hickley
Jack Kessler
Original Assignee
Symbollon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbollon Corp filed Critical Symbollon Corp
Publication of FI20011703A0 publication Critical patent/FI20011703A0/fi
Publication of FI20011703L publication Critical patent/FI20011703L/fi
Publication of FI20011703A7 publication Critical patent/FI20011703A7/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI20011703A 1999-02-26 2000-02-22 Jodidia ja jodaattia sisältävä stabiloitu oraalinen farmaseuttinen koostumus sekä menetelmä FI20011703A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/258,062 US6248335B1 (en) 1997-10-29 1999-02-26 Stabilized oral pharmaceutical composition containing iodide and iodate and method
PCT/US2000/004411 WO2000050046A1 (en) 1999-02-26 2000-02-22 Stabilized oral pharmaceutical composition containing iodide and iodate and method

Publications (3)

Publication Number Publication Date
FI20011703A0 FI20011703A0 (fi) 2001-08-24
FI20011703L true FI20011703L (fi) 2001-10-16
FI20011703A7 FI20011703A7 (fi) 2001-10-16

Family

ID=22978944

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20011703A FI20011703A7 (fi) 1999-02-26 2000-02-22 Jodidia ja jodaattia sisältävä stabiloitu oraalinen farmaseuttinen koostumus sekä menetelmä

Country Status (19)

Country Link
US (1) US6248335B1 (fi)
JP (1) JP2002537341A (fi)
KR (1) KR100674324B1 (fi)
CN (1) CN1344163A (fi)
AT (1) AT413795B (fi)
AU (1) AU778774B2 (fi)
BR (1) BR0008509A (fi)
CA (1) CA2366679C (fi)
DE (1) DE10084290T1 (fi)
DK (1) DK176595B1 (fi)
ES (1) ES2226514B2 (fi)
FI (1) FI20011703A7 (fi)
GB (1) GB2364641B (fi)
IL (1) IL144955A (fi)
MX (1) MXPA01008550A (fi)
NO (1) NO20014101L (fi)
SE (1) SE0102843L (fi)
WO (1) WO2000050046A1 (fi)
ZA (1) ZA200106451B (fi)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7147873B2 (en) * 2002-01-16 2006-12-12 3M Innovative Properties Company Antiseptic compositions and methods
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
EP2007225A1 (en) * 2004-12-24 2008-12-31 Council Of Scientific & Industrial Research An improved iodized salt and a process for its preparation
EP1838617B1 (en) * 2005-01-10 2013-07-31 Secretary, Department Of Atomic Energy Calcium potassium ferrocyanide, a prophylactic mixture comprising this compound and the use thereof for decorporation of radiocesium in subjects affected by nuclear radiation
US20080063560A1 (en) * 2006-09-07 2008-03-13 Biolargo Life Technologies, Incorporated Ground treatment for reducing microbial content
US7943158B2 (en) * 2006-09-07 2011-05-17 BioLargo Life Technologies, Inc Absorbent systems providing antimicrobial activity
US8021610B2 (en) * 2006-09-07 2011-09-20 Biolargo Life Technologies, Inc. Systems providing antimicrobial activity to an environment
US9414601B2 (en) * 2006-09-07 2016-08-16 Biolargo Life Technologies, Incorporated Material having antimicrobial activity when wet
US7867510B2 (en) * 2006-09-07 2011-01-11 BioLargo Life Technologies, Inc Material having antimicrobial activity when wet
US8226964B2 (en) * 2006-09-07 2012-07-24 Biolargo Life Technologies, Inc. Systems and methods for cleaning liquid carriers related applications data
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
US8257749B2 (en) * 2007-02-08 2012-09-04 Biolargo Life Technologies, Incorporated Systems providing at least pesticidal activity
WO2009087647A1 (en) * 2008-01-07 2009-07-16 Council Of Scientific & Industrial Research A stabilized iodine-water concentrate formulation useful for protection against iodine deficiency disorders
US9622911B2 (en) 2010-09-30 2017-04-18 Cxl Ophthalmics, Llc Ophthalmic treatment device, system, and method of use
ES2978927T3 (es) 2012-03-29 2024-09-23 Epion Therapeutics Inc Soluciones de tratamiento ocular, dispositivos de administración y métodos de aumento de la administración
EP2830554A1 (en) 2012-03-29 2015-02-04 CXL Ophthalmics, LLC Ocular cross-linking system and method for sealing corneal wounds
US9566301B2 (en) 2012-03-29 2017-02-14 Cxl Ophthalmics, Llc Compositions and methods for treating or preventing diseases associated with oxidative stress
WO2015080984A1 (en) 2013-11-27 2015-06-04 BioPharmX, Inc. Solid oral dosage form for breast symptoms
AU2015213577B2 (en) * 2014-02-10 2019-02-14 Fred Hutchinson Cancer Center Halogen treatment of heart attack and ischemic injury
US20170304359A1 (en) 2016-04-21 2017-10-26 BioPharmX, Inc. Oral iodine dosage form
US11596648B2 (en) 2016-07-21 2023-03-07 I2Pure Corp. Emollient topical disinfectants
WO2018053335A1 (en) * 2016-09-16 2018-03-22 Iogen Llc Oral molecular iodine composition and method
CA3102792A1 (en) * 2018-06-08 2019-12-12 Faraday Pharmaceuticals, Inc. Use of halogen compounds for the treatment and prevention of tissue injury and post-intensive care syndrome
WO2022036280A1 (en) 2020-08-13 2022-02-17 I2Pure Corp. High molecular iodine concentration compositions, pharmaceutical formulations, preparation and uses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486317A (en) * 1981-01-16 1984-12-04 E. I. Du Pont De Nemours And Company Stabilization of thickened aqueous fluids
RO85156B1 (ro) * 1983-05-27 1984-11-30 Institutul De Stiinte Biologice Comprimate-reactiv pentru determinarea alfa-anilazei si procedeu de obtinere a acestora
CN1036629C (zh) * 1991-03-16 1997-12-10 李克亮 动物促长剂
US5885592A (en) * 1997-10-29 1999-03-23 Symbollon Corporation Methods and pharmaceutical compositions for oral delivery of molecular iodine
CA2317587A1 (en) * 1998-01-06 1999-07-15 Fujisawa Pharmaceutical Co., Ltd. Solid iodophor preparations and process for producing the same
US5985340A (en) * 1998-01-19 1999-11-16 Bolentica, Inc. Method for preparing iodine supplement for animal feeds

Also Published As

Publication number Publication date
CA2366679C (en) 2007-05-01
JP2002537341A (ja) 2002-11-05
ES2226514B2 (es) 2007-02-16
GB2364641A (en) 2002-02-06
CA2366679A1 (en) 2000-08-31
DK200101258A (da) 2001-10-26
SE0102843D0 (sv) 2001-08-27
FI20011703A0 (fi) 2001-08-24
DK176595B1 (da) 2008-10-20
AU3371300A (en) 2000-09-14
WO2000050046A1 (en) 2000-08-31
AU778774B2 (en) 2004-12-23
BR0008509A (pt) 2002-02-05
US6248335B1 (en) 2001-06-19
WO2000050046A8 (en) 2003-11-27
ES2226514A1 (es) 2005-03-16
KR20010103014A (ko) 2001-11-17
MXPA01008550A (es) 2003-08-19
IL144955A0 (en) 2002-06-30
NO20014101D0 (no) 2001-08-23
GB0122808D0 (en) 2001-11-14
GB2364641B (en) 2004-06-30
KR100674324B1 (ko) 2007-01-24
FI20011703A7 (fi) 2001-10-16
DE10084290T1 (de) 2003-04-03
CN1344163A (zh) 2002-04-10
ZA200106451B (en) 2002-08-06
NO20014101L (no) 2001-10-12
ATA90122000A (de) 2005-10-15
AT413795B (de) 2006-06-15
SE0102843L (sv) 2001-10-26
IL144955A (en) 2006-12-31

Similar Documents

Publication Publication Date Title
FI20011703L (fi) Jodidia ja jodaattia sisältävä stabiloitu oraalinen farmaseuttinen koostumus sekä menetelmä
EE200200149A (et) Kinasoliinühendid ja neid sisaldavad ravimkoostised
DE69924999D1 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
DK0936913T3 (da) Oralt farmaceutisk præparat indeholdende ibandronat
DE69634053D1 (de) Oral anzuwendende Arzneizusammensetzung enthaltend 2-Methyl-thienobenzodiazepin
DE69940904D1 (de) Pharmazeutische zusammensetzung enthaltend epothilone
NO20020208L (no) Flytende sammensetninger for oral administrasjon
FI991485A0 (fi) Uusi farmaseuttinen koostumus
IL144910A0 (en) Cyclic compounds and pharmaceutical compositions containing the same
ATE331529T1 (de) Antigen enthaltende pharmazeutische zusammensetzung
FR2775596B1 (fr) Nouvelles compositions pharmaceutiques
HUP0203378A3 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
HUP0204580A3 (en) Aryl fused azapolycyclic compounds and pharmaceutical compositions containing them
DE69909135D1 (de) Orale zubereitung zur bekämpfung von mundgeruch
HUP0103256A3 (en) Thiobenzimidazole derivatives and pharmaceutical compositions containing the compounds
ID29262A (id) Komposisi farmasi
ITMI982222A0 (it) Composizioni farmaceutiche orali contenenti buprenorfina
DE69827357D1 (de) Menschliches Wachstumshormon enthaltende pharmazeutische Zusammensetzung
EE200200075A (et) Peroraalselt ja paikselt manustatavad farmatseutilised kompositsioonid
HUP0200747A3 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
ATE223705T1 (de) Rapamycin enthaltende formulierungen zur oralen verabreichung
FI953384L (fi) Uusi bentsolitiaditsiiniyhdiste, menetelmä sen valmistamiseksi ja sitä sisältävät farmaseuttiset koostumukset
EE200300135A (et) Trüptamiini derivaadid ja analoogsed ühendid ningneid sisaldavad farmatseutilised preparaadid
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
FR2779145B1 (fr) Nouvelles compositions pharmaceutiques